Qiao, Junjing
Liang, Chen
Zhao, Dandan
Nguyen, Le Xuan Truong
Chen, Fang
Suo, Shanshan
Hoang, Dinh Hoa
Pellicano, Francesca
Rodriguez, Ivan Rodriguez
Elhajmoussa, Yasmin
Ghoda, Lucy
Yoshimura, Akihiko
Stein, Anthony S.
Ali, Haris http://orcid.org/0000-0002-9728-7292
Koller, Paul
Perrotti, Danilo http://orcid.org/0000-0003-0726-8766
Copland, Mhairi http://orcid.org/0000-0002-7655-016X
Han, Anjia http://orcid.org/0000-0003-2245-1972
Zhang, Bin http://orcid.org/0000-0003-4703-7524
Marcucci, Guido http://orcid.org/0000-0002-3983-5908
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA248475, CA205247, CA248475, CA205247)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 8 March 2021
Revised: 31 August 2021
Accepted: 13 September 2021
First Online: 25 September 2021
Competing interests
: The authors declare no competing interests.
: Patient sample acquisition was approved by the Institutional Review Boards (IRB) at the COHNMC, in accordance with an assurance filed with and approved by the Department of Health and Human Services and met all requirements of the Declaration of Helsinki. CML patients were consented on the IRB #18067 protocol.